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Abstract A method for hemodialysis catheter placement
in patients with central thoracic venous stenosis or occlu-
sion is described and initial results are analyzed. Twelve
patients, with a mean age of 63.2 years (42–80 years), with
central venous stenosis or occlusion, and who required a
hemodialysis catheter were reviewed. All lesions were
confirmed by helical CT or phlebography. Five patients had
stenosis while seven patients were diagnosed with an
occlusion of thoracic central veins. All patients were
asymptomatic, without sign of superior vena cava syn-
drome. After percutaneous transstenotic catheterization or
guidewire-based recannalization in occlusions, a balloon
dilatation was performed and a stent was placed, when
necessary, prior to catheter placement. Technical success
was 92%. Three patients had angioplasty alone and nine
patients had angioplasty with stent placement. Dialysis
catheters were successfully inserted through all recannal-
ized accesses. No immediate complication occurred, nor
did any patient develop superior vena cava syndrome after
the procedure. The mean follow-up was 21.8 months
(range, 8–48 months). Three patients developed a catheter
dysfunction with fibrin sheath formation (at 7, 11, and
12 months after catheter placement, respectively). Two
were successfully managed by percutaneous endovascular
approach and one catheter was removed. In conclusion, for
patients with central venous stenosis or occlusion and those
who need a hemodialysis catheter, catheter insertion can be
reliably achieved immediately after endovascular recan-
nalization with acceptable technical and long-term success
rates. This technique should be considered as an alternative
procedure for placing a new hemodialysis catheter through
a patent vein.
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Introduction
Hemodialysis catheters (HCs) are widely used in dialyzed
patients even if they are placed only because other types of
hemodialysis access are not available or are not yet
available (immature fistulas). Temporary HCs are indicated
in patients who need a HC before a permanent arteriove-
nous fistula has been performed and in those with arterio-
venous fistula dysfunctions who need a major surgical
revision of their fistula. Permanent HCs are used in patients
with no alternative options for chronic dialysis access.
However, catheters still have a high risk of infections (up
to 50%) and fibrin sheath formation (40–50%) [1–4], which
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may induce venous obstructions and subsequent catheter
dysfunction. In cases of mechanical-related complications
such as venous and catheter obstructions, the catheter has
to be removed and another one then placed. Furthermore,
frequent catheter changes in central thoracic veins (CTVs)
might lead to their early obstruction, comprising future
access for hemodialysis. If the catheter is inserted in
another CTV, a new thrombosis may also induce superior
vena cava syndrome and the route for a future arteriove-
nous fistula could be compromised. In cases with no patent
access to the superior vena cava, the HC can be placed in
the inferior vena cava. However, the incidence of infection
is higher with HCs in the inferior vena cava, due to the
femoral access in the groin [5, 6]. An alternative option is
to use the occluded route for HC placement to avoid
potential consequences of venous obstruction after HC
placement [7–10]. We report our experience with CTV
recannalization in asymptomatic patients in order to place a
HC. The purpose of the study was to evaluate the feasi-
bility of placement of HCs in stenosed or occluded CTVs
in asymptomatic patients: technical success and procedure
safety were the primary end points of the study.
Materials and Methods
Between April 2002 and June 2005, patients at risk of
having CTV obstruction (patients with previous implanted
central venous catheters, patients with known CTV
obstruction, and patients who had catheter placement fail-
ure) and who needed HC placement were first screened
with ultrasound and or CT phlebography of the CTV and
were then treated according to our institutional guidelines
(Fig. 1). If there was any suspicion of venous obstruction at
ultrasound or CT phlebography, the CTV circulation was
evaluated by phlebography prior to HC placement.
During this period, 12 patients who were candidates for
HC placement had CTV stenosis or occlusion. All patients
were long-term-dialyzed patients with numerous prior
arteriovenous fistulas or HCs and needed a new HC for two
different indications: patients who needed a permanent HC
because there was no other option to create an arteriove-
nous fistula (n = 5), and patients who needed a temporary
HC because of major surgical revision on an arteriovenous
fistula (n = 7). The mean age was 63.2 years (range,
42–80 years) (Table 1 summarizes demographic data on
the study population). All patients were asymptomatic
before the procedure regarding CTV obstruction (the Kishi
score for clinical signs of superior vena cava [SVC]
obstruction was \4 for all patients). Helical CT phlebog-
raphy using the technique described by Qanadli et al. [11]
(n = 2) or digital phlebography (n = 11) was done prior to
the procedure to evaluate the CTV circulation including
stenosis and occlusion evaluation and collateral supply
assessment. In one patient, helical CT phlebography failed
and a digital phlebography had to be performed. Five
patients had stenosis, four located on the left brachioce-
phalic vein and one on the right brachiocephalic vein,
while seven other patients had occlusion. Three occlusions
were located on the brachiocephalic vein, and two in the
SVC. Two patients had occlusion of the SVC and stenosis
of the left brachiocephalic vein. The side for HC placement
was chosen according to the venous obstruction or occlu-
sion and leaving the patent veins free for cerebral venous
drainage and future dialysis access. According to previous
studies [12], we used the jugular access for HD catheter
insertion first whenever it was possible. The subclavian
access was used as a second choice for HD placement. All
patients gave their informed consent for the procedure.
Procedures were performed in the interventional suite
using standard digital fluoroscopic equipment. Seven pro-
cedures were performed under local anesthesia and the
remaining five were performed under general anesthesia.
Two patients refused local anesthesia and in three patients
we expected a long procedure time and the patients pre-
ferred general anesthesia based on previous experience.
Five patients were outpatients and seven patients were
hospitalized for their shunt revision. Nine patients were on
aspirin prior to the procedure, two were on coumarin, and
Fig. 1 Institutional flowchart for hemodialysis catheter placement in
patients with central vein obstruction
696 C. Haller et al.: Placement of Hemodialysis Catheters
123
one had neither aspirin nor coumarin. After stenting, the
patients were on long-term aspirin or coumarin as they
were before. Anticoagulants were given intravenously
(3000–5000 IU of sodium heparin) during the procedure. A
single dose of 1 g of vancocin as antibiotic prophylaxis was
also given before the procedure.
Revascularization Technique
The right femoral vein (n = 10), the jugular vein (n = 3),
or the fistula (n = 2) was punctured with an 18-gauge
needle. We used the femoral or the shunt as the first choice
of access depending on the location of the obstruction. In
two situations, we had an occlusion of the left brachioce-
phalic vein and a stenosis of the SVC. In these situations,
we used the only drainage of the head as access for the HC;
it is essential to keep permeability of the vein with a stent.
(a) In patients with complete venous obstruction (n = 7),
a balloon angioplasty was done after recannalization
until a sufficient diameter was reached to allow HC
placement. Considering the HC size, a 10-mm balloon
(balloon pressure ranging from 6 to 12 atm) was used.
A gradual angioplasty was done where necessary,
starting with a balloon of 6 mm. If the optimal
diameter was not reached with balloon dilatation
(n = 2) alone, as well as in patients with clot
formation at the site of dilatation (n = 3), a self-
expanding stent was deployed (five of seven) to
improve the diameter, facilitate HC implantation, and
prevent distal emboli during HC implantation
(Fig. 2). The distal extremity of the stent required
precise deployment to make sure that the HC could be
inserted into the stent. For this reason, Nitinol-based
self-expanding stents were preferred. A phlebography
was obtained at the end of the procedure to check for
adequate release and location of the stent, as well as
patency of the venous system, before HC placement.
(b) In patients with venous stenosis (n = 5), a balloon
angioplasty was done (balloon pressure ranging from
6 to 12 atm) (Fig. 3); if the optimal diameter was
not reached with balloon dilatation (residual stenosis
\30%), a self-expanding stent (n = 4) was deployed
to avoid occlusion of the vein after HC insertion.
Phlebography was obtained to check for adequate
release and location of the stent and patency of the
venous system. In patients with complex stenosis or
occlusions, we used a combined approach by a
femoral and jugular access.
(c) For the HC insertion technique, an 18-gauge needle
puncture was used to gain access to the jugular vein,
if this was not already done for venous recannaliza-
tion, or to the subclavian vein as second choice. For a
temporary HC, the short-term 11.5-Fr Duo-Flow XTP
with 20-cm double-lumen catheter (Medcomp, Har-
leysville, PA, USA) was used. The HC was fully
inserted, the catheter tip was positioned in the right
atrium junction under fluoroscopic guidance, and the
HC was sutured into position. The HC was checked
for backflow and flushed with heparin solution.
For a permanent HC, the long-term catheter 10-Fr Bio-
Flex Tesio with football cuff (27-cm arterial, 30-cm venous
cuff placement; Medcomp) was used. The two HCs were
fully inserted and the catheter tips were positioned in the
right atrium junction with the SVC under fluoroscopic
guidance (Fig. 4). The HCs were checked for backflow and
flushed with heparin solution.
In three patients, the HC could not be advanced through
the recannalized access: a 6-Fr, 25-mm Amplatz Goose
Neck snare device (EV3, Plymouth, MA, USA) was
introduced by the femoral approach through the
Table 1 Demographic data on the study population
Patient no. Gender Age (year) Arteriovenous fistula Stenosis Occlusion
1 F 80 None Left BCV
2 F 69 None SVC Left BCV
3 M 43 Upper arm prosthetic fistula Left BCV
4 F 63 Upper arm prosthetic fistula SVC
5 M 50 None SVC Left BCV
6 M 69 None Left BCV
7 M 49 Forarm prosthetic fistula Left BCV
8 F 68 Forarm prosthetic fistula Right BCV
9 M 77 None Right BCV
10 M 44 Native radiocephalic fistula SVC
11 M 68 Upper arm prosthetic fistula Left BCV
12 M 78 Forarm prosthetic fistula Right BCV
Note: F female, M male, SVC superior vena cava, BCV brachiocephalic vein
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recannalized access to trap the HC catheter in the jugular or
the subclavian vein and facilitate the pulling maneuver
through the stent or stenosis site into the SVC. At the end
of the procedure, a controlled fluoroscopy was done to
check the accurate position of the HC.
Complications
All complications during the procedure or related to the
procedure were reported. After the procedure, all patients
were followed at the dialysis center and all catheter dys-
functions or symptoms of venous obstruction were repor-
ted. All complications related to the HC were noted during
the time that the HC was in place. If a HC dysfunction was
reported, phlebography was performed to evaluate the HC
dysfunction. If it was not used, the HC was removed. After
HC removal, the patient was only clinically followed up for
SVC syndrome; no phlebograhy was performed to assess
the venous permeability during follow-up.
Results
Revascularization procedures were done by the femoral
approach alone in seven patients (58%). A combined jug-
ular and femoral approach was necessary in long occlusion
Fig. 2 An 80-year-old woman
with chronic kidney disease
(diabetes and hypertension) who
was dialyzed for 4 years. After
failure of peritoneal dialysis,
she had a left jugular dialysis
catheter inserted, which was
removed for dysfunction due to
a pericatheter thrombosis.
Another catheter was inserted
into the right subclavian vein. It
also had to be removed, due to
for dysfunction, and a
temporary femoral catheter was
placed. Phlebography of the
thoracic venous circulation, by a
right femoral approach, shows
occlusion of the right and left
brachiocephalic veins and a
stenosis of the superior vena
cava. The left jugular vein is
patent (A). Angioplasty of the
left brachiocephalic vein was
performed (B) and a self-
expanding stent (10 9 80 mm)
was placed (C) from the left
jugular vein through the left
brachiocephalic vein into the
superior vena cava. At the end,
patency of the stent was
controlled by phlebography (D)
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or complex stenosis in three patients (25%), and in two
patients (17%) the procedure was done through the arte-
riovenous fistula. Technical success of percutaneous re-
cannalization was 92% (11/12). One patient could not be
recannalized. After a femoral approach the guidewire was
passed through the SVC and the left brachiocephalic vein
into the subclavian vein. The guidewire could not be
caught either by a left jugular percutaneous approach or by
a surgical subclavian approach of the occluded subclavian
vein.
Three patients had only angioplasty, while six patients
had angioplasty with one stent placement and three others
had two stents. The stents (n = 12) were implanted in the
brachiocephalic vein (n = 10) and in the SVC (n = 2) as
listed in Table 2. HCs were successfully inserted through
all recannalized accesses. Six HCs (two permanent and
four temporary) were inserted by a jugular approach, which
was our first choice. Five HCs (all permanent) were
inserted by a subclavian approach, when the jugular access
was not possible. The patient with revascularization failure
of the SVC system had a femoral catheter inserted. No
complication related to the procedure was observed. All
patients remain asymptomatic and no patient developed
SVC syndrome after the procedure and during follow-up.
All HCs were functional after the procedure and we used a
flow rate of 300 ml/min for hemodialysis, without any
problem. The mean follow-up was 21.8 months (range,
8–48 months). At 3, 11, and 12 months, respectively, after
HC placement, three patients developed HC dysfunction.
In all cases, phlebography showed fibrin sheath formation,
Fig. 3 A 79-year-old man with
chronic kidney disease, dialyzed
for 12 years. In the past, many
central venous catheters had
been placed on both sides. He
had surgery on his left right arm
arteriovenous fistula and needed
a temporary catheter for
dialysis. Phlebography of the
thoracic venous circulation by a
right femoral access shows
stenosis of the superior vena
cava (A). An angioplasty was
performed with a 14/40-mm
balloon (B). Control
phlebography shows no residual
stenosis on the superior vena
cava (C) and a patent left
brachiocephalic vein (D)
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which was successfully managed by percutaneous endo-
vascular stripping in two cases using a snare loop tech-
nique. In the other patients, the HC was removed because
the arteriovenous fistula was ready for use. No bloodstream
infection was noted during this follow-up and no HC
infection was reported.
Discussion
The venous capital is of limited possibilities and we should
preserve it as much as we can. This capital can be lifesaving
in patients with terminal kidney disease who need dialysis.
Every catheter may induce a pericatheter thrombosis, which
can impair blood flow and cause vein obstruction. Consid-
ering the high incidence of catheter-related venous throm-
bosis, up to 60% (range, 0–60%) [1–4], we believe that the
best way to prevent venous thrombosis is to avoid catheter
placement in patent veins. The organization of the thrombus
may cause stenosis or chronic venous occlusion, which
often remains asymptomatic [13, 14]. In the setting of
chronic CTV stenosis or occlusion, venous collateral path-
ways may develop progressively, providing alternative
routes of blood flow over time [15] and, thus, avoiding SVC
syndrome. In asymptomatic patients with chronic venous
obstruction, the placement of a central venous catheter may
induce new venous thrombosis or impair the quality of
venous collaterals, resulting in a high risk for developing
SVC syndrome and catheter dysfunction.
Patients with chronic kidney disease should be advised
to preserve their veins and a primary permanent arterio-
venous fistula should be performed to avoid HC placement
[16]. If no other possibility is available, the HC should be
Fig. 4 Two guidewires were placed by a left jugular approach
through the stent in the superior vena cava. After verification of good
position of the guidewires, the catheters were placed over the wires
into the peel-away sheath under fluoroscopic guidance. After the peel-
away sheaths were removed and the catheter tips placed in the right
position, the catheters were placed in a subcutaneous position
Table 2 Angioplasty, stents, and catheters
Patient no. No. of
stents
Type of stenta Stent size (mm)b Venous
access
Catheterc Catheter
location
Follow-
up
(months)
1 1 Wallstent 10 9 80 F and J Bio-Flex Tesio J 48
2 2 Wallstent 12 9 60/12 9 60 F and J Bio-Flex Tesio J 38
3 1 Philon 12 9 60 F Duo-Flex XTP J 25
4 1 Luminexx 16 9 60 F Bio-Flex Tesio S 24
5 0 F and J Duo-Flex XTP F 21
6 2 Luminexx 10 9 60/10 9 40 F Bio-Flex Tesio S 21
7 2 Smart 8 9 40/12 9 40 F Duo-Flex XTP J 19
8 1 Smart 12 9 40 F Bio-Flex Tesio S 18
9 1 Smart 12 9 40 AVF Duo-Flex XTP J 16
10 0 F Bio-Flex Tesio S 14
11 1 Smart 14 9 60 AVF Duo-Flex XTP J 10
12 0 F Bio-Flex Tesio S 8
Note: F femoral, J jugular, S subclavian, AVF arteriovenous fistula
a Wallstent (Boston Scientific Corp., Natick, MA,USA); Philon (Biotronik Inc., Lake Oswego, OR, USA); Luminexx (Bard Peripheral Vascular,
Inc., Tempe, AZ, USA); Smart (Cordis Corp., Miami Lakes, FL, USA)
b Diameter 9 length
c Bio-Flex Tesio, long-term dialysis catheter (Medcomp, Harleysville, PA, USA); Duo-Flow XTP, short-term dialysis catheter (Medcomp)
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placed in the CTV. In the case of CTV obstructions, we
developed the concept of placing the HC on the nonfunc-
tional venous axis to minimize the risk of developing SVC
stenosis after HC placement. Placement of the HC in pre-
viously occluded veins (Stanford types III and IV) should
preserve the venous capital and lower the risk of devel-
oping severe mechanical-related complications. The
objective of the recannalization procedure is to place a
functional catheter into the CTV, rather than vein patency.
For this purpose, percutaneous transluminal angioplasty is
sufficient to reopen the route to the CTV when there are no
clots and allows HC placement. In the case of stenosis of
the CTV system (Stanford types I and II), care should be
taken to avoid the risk of venous obstruction and sub-
sequent SVC syndrome after HC placement. For this rea-
son and in the presence of blood clots, angioplasty and
stent are justified [11].
Stent deployment is an established option for benign
CTV stenosis [17– 20]. Stents are also particularly useful in
rigid, distorted, and collapsing stenoses and in treatment of
vessel injuries after recannalization as well as in extrinsic
fibrotic compression [21]. Placement of an undersized stent
will lead to migration or thrombosis and the oversizing
concept may increase pressure and stimulate intimal
hyerplasia development with the occurrence of intrastent
stenosis [22]. We prefer self-expanding stent oversizing, as
recommended by other authors [15], with a stent diameter
15–20% greater than the vein over which it is placed.
Therefore, demonstration of good blood flow through the
CTV with markedly reduced collateral circulation on
poststenting phlebography represents a good criterion forf
immediate technical success and allows placement of the
HC. Stents should always be placed in such a fashion that
they do not cover the origin of other main veins or com-
promise future surgery. If it is not possible, no stent should
be placed and angioplasty alone should be considered,
especially in cases with obstruction. Long-term patency in
these asymptomatic patients is not a major issue. Potential
complications of stent deployment in the CTV system
include venous rupture, stent misplacement, and stent
migration [22, 23]. Minor venous ruptures during the per-
cutaneous transluminal angioplasty procedure are reported
to be frequent [24]. However, they usually seal spontane-
ously or with prolonged low-pressure inflation of the bal-
loon. In larger venous ruptures, deployment of a stent by
radial expansion can stop bleeding, while treating stenoses
related to vessel injury and hematoma and avoiding the
development of pseudoaneurysms [17]. In the case of
venous rupture, a stent-graft is another possibility for
sealing off the site of the rupture. Hemopericardium an
hemothorax are rare but potential life-threatening compli-
cations. Migration of the stent is also a rare complication
[25]. Late complications include recurrence of the stenosis
due to intimal hyperplasia and fibrin sheath. The fibrin
sheath is considered to be the first cause of catheter dys-
function [26]. During our follow-up, we observed three
fibrin sheaths (25%). Most cases of fibrin sheath can be
treated by a femoral percutaneous endovascular approach
and do not require removal of the HC. Placement of stents
is technically and particularly delicate at the junction of the
subclavian and brachiocephalic veins because of the dif-
fering luminal size compared with the CTV.
There are other alternative routes for placing a HC in the
case of a CTV obstruction. If the stenosis is not located in
the CTV, an option is another patent vein of the CTV
system. But the risk of SVC syndrome is high in the case of
a new pericatheter thrombosis. The femoral route, which is
another alternative, should only be chosen if an access to
the SVC has been excluded and is mainly reserved for
temporary access [27]. The risk of infection is higher with
the transfemoral approach than in the CTV system.
Transrenal, translumbar, and transhepatic routes have been
reported as yet other alternatives [ 28–31]. The translumbar
access is generally preferred because of the low infection
and thrombosis rates.
In conclusion, treatment of CTV stenosis or occlusion in
asymptomatic patients in order to place a HC is a feasible
and safe alternative technique for hemodialysis patients.
This technique is strongly recommended for candidates
who need HC placement, as it preserves the venous reserve
and avoids major mechanical thrombosis after HC place-
ment. Further evaluations are needed to define clinical
indications and patient selection more clearly and to assess
long-term HC function and the clinical impact of HCs
placed in recannalized vein compared to HCs placed using
standard routes.
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